• 1
    Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. Ca Cancer J Clin 1996; 65: 527.
  • 2
    Hartman DS, Davis CJ Jr., Madewell JE, Friedman AC. Primary malignant renal tumors in the second decade of life: Wilms tumor versus renal cell carcinoma. J Urol 1982; 127: 88891.
  • 3
    Davis CJ Jr., Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 1995; 19: 111.
  • 4
    Kennedy SM, Merino MJ, Linehan WM, Roberts JR, Robertson N, Newmann RD. Collecting duct carcinoma of the kidney. Hum Pathol 1990; 21: 44956.
  • 5
    Davidson AJ, Choyke PL, Hartman DS, Davis CJ Jr. Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology 1995; 195: 835.
  • 6
    Malek RS, Omess PJ, Benson RC, Zincke H. Renal cell carcinoma in von Hippel-Lindau syndrome. Am J Med 1987; 82: 2368.
  • 7
    Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs S, et al. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 1979; 301: 5925.
  • 8
    Li FP, Decker HJH, Zbar B, Stanton Jr. VP, Kovacs G, Seizinger BR, et al. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional 3;8 translocation. Genetics of familial renal carcinoma. Ann Intern Med 1993; 118: 10611.
  • 9
    Deisseroth A, Nienhuis A, Lawrence J, Giles R, Turner P, Ruddle FH. Chromosomal localization of human β-globin gene on human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci USA 1978; 75: 145660.
  • 10
    Perkins AS, Vande Woude GF. Principles of molecular cell biology of cancer: oncogenes. In: DevitaVT, HellmanS, RosenbergSA, editor, Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia: J.B. Lippincott Co, 1993: 3559.
  • 11
    Strohmeyer TG, Slamon DJ. Proto-oncogenes and tumor suppressor genes in human urological malignancies. J Urol 1994; 151: 147997.
  • 12
    Ruckdeschel JC, Finkelstein DM, Mason BA, Creech RH. Chemotherapy for metastatic nonsmall bronchogenic carcinoma, generation V—a randomized comparison of four cisplatin containing regimens. J Clin Oncol 1985; 3: 729.
  • 13
    Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, et al. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988; 318: 141422.